Antibiotic Treatment for Bacterial Upper Respiratory Tract Infections in Children

First-Line Treatment Options

The American Academy of Pediatrics recommends amoxicillin as the first-line antibiotic treatment for children with bacterial upper respiratory tract infections, with dosing of 45-90 mg/kg/day depending on infection severity and local resistance patterns 1, 2
For mild to moderate infections, the American Academy of Pediatrics suggests amoxicillin should be dosed at 45 mg/kg/day divided into two doses or 40 mg/kg/day divided into three doses 2
For severe infections or when drug-resistant pathogens are suspected, the American Academy of Pediatrics recommends higher dosing of 90 mg/kg/day 2
For children under 3 years with suspected bacterial pneumonia, the European Society for Clinical Microbiology and Infectious Diseases recommends amoxicillin 80-100 mg/kg/day in three daily doses 3

The American Academy of Pediatrics suggests considering amoxicillin-clavulanate for children with severe symptoms, recent antibiotic exposure, known high local prevalence of amoxicillin-resistant Haemophilus influenzae, or insufficient vaccination against H. influenzae type b 2, 4, 3
In areas with high prevalence of penicillin-resistant S. pneumoniae, the American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate (90 mg/6.4 mg per kg per day) 2

The American Academy of Pediatrics recommends a treatment duration of 5 days for uncomplicated acute otitis media 2
For acute bacterial rhinosinusitis, the American Academy of Pediatrics suggests a treatment duration of 5-8 days 2

The American Academy of Pediatrics recommends evaluating response to therapy after 48-72 hours, and considering treatment failure if there is a lack of improvement 2
Macrolides and oral third-generation cephalosporins have high rates of pneumococcal resistance, making them poor choices for most children with suspected bacterial URTIs 4
The American Academy of Pediatrics suggests that observation (wait-and-see approach) may be considered as an alternative strategy to immediate antibiotic therapy for older children without severe symptoms 4

The American Academy of Pediatrics notes that antibiotics can cause adverse events ranging from mild (diarrhea and rash) to severe (Stevens-Johnson syndrome) and life-threatening reactions (anaphylaxis) 1
Amoxicillin-clavulanate has a higher rate of adverse events (particularly diarrhea) compared to amoxicillin alone 1, 4
The American Academy of Pediatrics warns that early-life antibiotic exposures may disrupt the microbiome, potentially contributing to long-term health effects such as inflammatory bowel disease, obesity, eczema, and asthma 1
Judicious use of antibiotics is essential to minimize the impact of antibiotic overuse on resistance in individuals and communities 1, 4

The American Academy of Pediatrics recommends 10-day treatment courses for children under 2 years with Acute Otitis Media (AOM) 5
For Acute Bacterial Rhinosinusitis, an alternative approach is to treat for 7-10 days, continuing until symptom-free for 7 days, typically 10-14 days total, as suggested by the Journal of Allergy and Clinical Immunology 6
Some cephalosporins, such as cefuroxime-axetil and cefpodoxime-proxetil, have demonstrated efficacy with 5-day courses for Acute Bacterial Rhinosinusitis, according to the Journal of Allergy and Clinical Immunology 6

For severe infections or resistant pathogens, the American Academy of Otolaryngology-Head and Neck Surgery recommends a dose of 90 mg/kg/day (amoxicillin component) 6, 7
The high-dose regimen for amoxicillin-clavulanate is 90 mg/6.4 mg per kg per day, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery and the Clinical Microbiology and Infection journal 7, 8

The American Academy of Pediatrics suggests that children under 2 years with AOM may benefit from 10-day treatment courses 5
Recent antibiotic exposure (within 4-6 weeks) may warrant 10-day treatment courses, according to the American Academy of Otolaryngology-Head and Neck Surgery 7
Severe symptoms at presentation may require 10-day treatment courses, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 7
Bilateral AOM in young children may benefit from 10-day treatment courses, according to the American Academy of Pediatrics 5
Immunocompromised patients may require 10-day treatment courses, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 7
Treatment failure after an initial shorter course may warrant 10-day treatment courses, according to the Journal of Allergy and Clinical Immunology 6